12
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
1276.HK · HKSE
$44.10 -4.01% (-$1.84)
1M -19.58%
Market Cap $305.4B
P/E Ratio 35.18x
Div. Yield -
ROE 12.40%
Piotroski F-Score Moderate
4/9Valuation
12 /100
Expensive P/B 4.10x
P/S 8.71x
P/E 35.18x
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
99 /100
Strong FCF margin 18.02%
Op. margin 24.33%
Gross margin 85.04%
Quality
58 /100
Average Asset turnover 0.43x
ROA 10.62%
ROIC 9.92%
Debt
100 /100
Low Net debt/EBITDA -4.72x
Int. coverage 1,325.95x
Debt/Equity 0.01x
Stability
0 /100
Unstable Beta 0.12x
EPS volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 1276.HK
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sun Piaoyang
Employees
20,602
Headquarters
Lianyungang
Evenimente viitoare
23 OCT.
Earnings
Upcoming earnings report